Whether activation of the HIF pathway by HIF-P4H inhibitors in peripheral tissues, such as the key regulators of glucose metabolism and insulin signaling; liver, WAT, and skeletal muscle could contribute to AD protection remains to be studied. The gene discussed is INS; the disease is Alzheimer disease.